Pierre Bogaerts

4.9k total citations
111 papers, 3.4k citations indexed

About

Pierre Bogaerts is a scholar working on Molecular Medicine, Endocrinology and Epidemiology. According to data from OpenAlex, Pierre Bogaerts has authored 111 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Medicine, 37 papers in Endocrinology and 31 papers in Epidemiology. Recurrent topics in Pierre Bogaerts's work include Antibiotic Resistance in Bacteria (84 papers), Bacterial Identification and Susceptibility Testing (30 papers) and Enterobacteriaceae and Cronobacter Research (25 papers). Pierre Bogaerts is often cited by papers focused on Antibiotic Resistance in Bacteria (84 papers), Bacterial Identification and Susceptibility Testing (30 papers) and Enterobacteriaceae and Cronobacter Research (25 papers). Pierre Bogaerts collaborates with scholars based in Belgium, France and Germany. Pierre Bogaerts's co-authors include Y. Glupczynski, Te‐Din Huang, C. Berhin, Thierry Naas, A. Deplano, Olivier Denis, Caroline Bauraing, Patrice Nordmann, Gaëlle Cuzon and Stéphanie Evrard and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Pierre Bogaerts

107 papers receiving 3.4k citations

Peers

Pierre Bogaerts
Pierre Bogaerts
Citations per year, relative to Pierre Bogaerts Pierre Bogaerts (= 1×) peers Delphine Girlich

Countries citing papers authored by Pierre Bogaerts

Since Specialization
Citations

This map shows the geographic impact of Pierre Bogaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Bogaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Bogaerts more than expected).

Fields of papers citing papers by Pierre Bogaerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Bogaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Bogaerts. The network helps show where Pierre Bogaerts may publish in the future.

Co-authorship network of co-authors of Pierre Bogaerts

This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Bogaerts. A scholar is included among the top collaborators of Pierre Bogaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Bogaerts. Pierre Bogaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deckers, C, Pierre Bogaerts, Patrick M. Honoré, et al.. (2025). Evaluation of Serum Biomarkers for Improved Diagnosis of Candidemia. Journal of Fungi. 11(3). 224–224. 2 indexed citations
2.
Montesinos, Isabel, Te‐Din Huang, Pierre Bogaerts, et al.. (2024). Diagnostic Value of Serum Biomarkers for Invasive Aspergillosis in Haematologic Patients. Journal of Fungi. 10(9). 661–661. 1 indexed citations
3.
Mercuri, Paola Sandra, Marylène Vandevenne, Frédéric Kerff, et al.. (2023). Development of Nanobodies as Theranostic Agents against CMY-2-Like Class C β-Lactamases. Antimicrobial Agents and Chemotherapy. 67(4). e0149922–e0149922. 6 indexed citations
6.
Deckers, C, Reza Soleimani, Olivier Denis, et al.. (2022). Multicentre interlaboratory analysis of routine susceptibility testing with a challenge panel of resistant strains. Journal of Global Antimicrobial Resistance. 28. 125–129. 1 indexed citations
7.
Soleimani, Reza, C Deckers, Te‐Din Huang, et al.. (2021). Rapid COVID‐19 antigenic tests: Usefulness of a modified method for diagnosis. Journal of Medical Virology. 93(9). 5655–5659. 12 indexed citations
8.
Bourgeois, Marc, Louis De Cannière, Isabelle Michaux, et al.. (2020). Severe influenza/respiratory syncytial virus infections and hospital antimicrobial stewardship opportunities: impact of a 4-year surveillance including molecular diagnosis. Infection Control and Hospital Epidemiology. 41(10). 1184–1189. 1 indexed citations
9.
Ceyssens, Pieter‐Jan, Pierre Bogaerts, Kevin Vanneste, et al.. (2020). Development of an NGS-Based Workflow for Improved Monitoring of Circulating Plasmids in Support of Risk Assessment of Antimicrobial Resistance Gene Dissemination. Antibiotics. 9(8). 503–503. 11 indexed citations
10.
Proia, Lorenzo, Adriana Anzil, Carles Borrego, et al.. (2018). Occurrence and persistence of carbapenemases genes in hospital and wastewater treatment plants and propagation in the receiving river. Journal of Hazardous Materials. 358. 33–43. 73 indexed citations
11.
Roisin, Sandrine, T.-D. Huang, Ricardo De Mendonça, et al.. (2017). Prospective evaluation of a high multiplexing real-time polymerase chain reaction array for the rapid identification and characterization of bacteria causative of nosocomial pneumonia from clinical specimens: a proof-of-concept study. European Journal of Clinical Microbiology & Infectious Diseases. 37(1). 109–116. 8 indexed citations
12.
Huang, T.-D., et al.. (2016). Increasing incidence of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in Belgian hospitals. European Journal of Clinical Microbiology & Infectious Diseases. 36(1). 139–146. 24 indexed citations
13.
Bogaerts, Pierre, Roberta Rezende de Castro, Ricardo De Mendonça, et al.. (2013). Validation of carbapenemase and extended-spectrum  -lactamase multiplex endpoint PCR assays according to ISO 15189. Journal of Antimicrobial Chemotherapy. 68(7). 1576–1582. 104 indexed citations
14.
Glupczynski, Y., Te‐Din Huang, Warda Bouchahrouf, et al.. (2011). Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. International Journal of Antimicrobial Agents. 39(2). 168–172. 106 indexed citations
15.
Bogaerts, Pierre, Isabel Montesinos, Hector Rodriguez‐Villalobos, et al.. (2009). Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing KPC-2 carbapenemase in Belgium. Journal of Antimicrobial Chemotherapy. 65(2). 361–362. 23 indexed citations
16.
Bogaerts, Pierre, et al.. (2008). Evaluation of a new meropenem–EDTA double-ended Etest strip for the detection of the CfiA metallo-β-lactamase in clinical isolates of Bacteroides fragilis. Clinical Microbiology and Infection. 14(10). 973–977. 10 indexed citations
17.
Bogaerts, Pierre, Thierry Naas, Caroline Bauraing, et al.. (2007). Imported cases of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in Belgium: characterisation and unusual loss of resistance. Digital Access to Libraries. 62(6). 457–457.
18.
Burteau, Sophie, Pierre Bogaerts, Léonid M. Irenge, et al.. (2007). Design and validation of a low density array (Nosochip) for the detection and identification of the main pathogenic bacteria and fungi responsible for nosocomial pneumonia. European Journal of Clinical Microbiology & Infectious Diseases. 27(1). 17–27. 6 indexed citations
19.
Bogaerts, Pierre, et al.. (1996). Activity of plasma membrane H + -ATPase and expression of PMA1 and PMA2 genes in S accharomyces cerevisiae cells grown at optimal and low pH. Archives of Microbiology. 166(5). 315–320. 58 indexed citations
20.
Bogaerts, Pierre, et al.. (1993). Identification and characterization of a second plasma membrane H+-ATPase gene subfamily in Nicotiana plumbaginifolia. Plant Molecular Biology. 21(6). 955–963. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026